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Disparate Evolution of Right and
Left Atrial Rate During Ablation of
Long-Lasting Persistent Atrial Fibrillation
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Sanjiv M. Narayan, MD, Pierre Jaïs, MD, Kang-Teng Lim, MD, Sébastien Knecht, MD,
Seiichiro Matsuo, MD, Andrei Forclaz, MD, Shinsuke Miyazaki, MD, Amir Jadidi, MD,
Mark D. O’Neill, MB, BCH, DPHIL, Frédéric Sacher, MD, Jacques Clémenty, MD,
Michel Haïssaguerre, MD
Bordeaux, France
Objectives The purpose of this study was to assess whether additional ablation in the right atrium (RA) improves termina-
tion rate in long-lasting persistent atrial fibrillation (PsAF).
Background Prolongation of atrial fibrillation (AF) cycle length (CL) measured from the left atrial appendage predicts favor-
able outcome during catheter ablation of PsAF. However, in some patients, despite prolongation of AF CL in the
left atrium (LA) with ablation, AF persists. We hypothesized that this persistence is due to RA drivers, and that
these patients may benefit from RA ablation.
Methods In all, 148 consecutive patients undergoing catheter ablation of PsAF (duration 25  32 months) were studied.
AF CL was monitored in both atria during stepwise ablation commencing in the LA. Ablation was performed in
the RA when all LA sources in AF had been ablated and an RA-LA gradient existed. The procedural end point
was AF termination.
Results Two distinct patterns of AF CL change emerged during LA ablation. In 104 patients (70%), there was parallel
increase of AF CL in LA and RA culminating in AF termination (baseline: LA 153 ms [range 140 to 170 ms], RA
155 ms [range 143 to 171 ms]; after ablation: LA 181 ms [range 170 to 200 ms], RA 186 ms [range 175 to
202 ms]). In 24 patients (19%), RA AF CL did not prolong, creating a right-to-left frequency gradient (baseline:
LA 142 ms [range 143 to 153 ms], RA 145 ms [range 139 to 162 ms]; after ablation: LA 177 ms [range 165 to
185 ms], RA 152 ms [range 147 to 175 ms]). These patients had a longer AF history (23 months vs. 12
months, p  0.001), and larger RA diameter (42 mm vs. 39 mm, p  0.005), and RA ablation terminated
AF in 55%. In the remaining 20 patients, biatrial ablation failed to terminate AF.
Conclusions A divergent pattern of AF CL prolongation after LA ablation resulted in a right-to-left gradient, demonstrating that
the right atrium is driving AF in 20% of PsAF. (J Am Coll Cardiol 2010;55:1007–16) © 2010 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.060fi
a
a
t
a
s
n
(
i
t
aeft atrium (LA) tissue is often necessary to ablate in
ddition to pulmonary vein isolation (PVI) to achieve
ptimal results in patients with long-lasting persistent atrial
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009, accepted September 15, 2009.brillation (PsAF) (1–12). During ablation, prolongation of
trial fibrillation (AF) cycle length (CL) occurs in the left
trium with its magnitude predicting procedural termina-
ion of AF. However, the need for right atrium (RA)
blation has not yet been clearly established in studies using
urgery or catheter ablation (13), with some studies showing
o utility of RA ablation and other studies showing benefit
14). As a result, it is unclear whether it is possible to
dentify a subset of patients who may benefit from addi-
ional RA ablation for long-lasting PsAF.
We hypothesized that failure to terminate AF after LA
blation is due to RA drivers, and these patients may benefit
rom additional RA ablation. Furthermore, we evaluated the
a
r
e
a
f
L
a
t
t
v
a
t
c
s
L
t
f
q
i
w
p
a
2
p
C
a
p
c
i
3
t
s
I
S
o
d
i
c
p
f
r
l
1008 Hocini et al. JACC Vol. 55, No. 10, 2010
Role of RA in Long-Lasting Persistent AF March 9, 2010:1007–16clinical and procedural factors
predictive of the need for RA
ablation, the extent of ablation
required, its impact on AF ter-
mination, and long-term clinical
outcome.
Methods
Study population. This study
population consisted of 148 con-
secutive patients (119 males, age
58 10 years) with symptomatic
long-lasting PsAF referred for
catheter ablation. Baseline charac-
teristics are presented in Table 1.
Electrophysiologic study. All pa-
tients provided written informed
consent. Antiarrhythmics agents
were discontinued 5 half-lives
before ablation, with the exception
of amiodarone. Before the proce-
dure, patients were receiving oral
nticoagulant agents targeting an international normalized
atio of 2 to 3 for at least 1 month, and transesophageal
chocardiography was performed within 5 days to exclude
trial thrombus. A transthoracic echocardiogram was per-
ormed within 1 week preceding the procedure. The RA and
A longitudinal and transverse diameters were measured in the
pical view at end-systole from the tip of the mitral or
ricuspid valve to the posterior wall of the LA or RA, and
he LA parasternal diameter in the parasternal long-axis
iew at end-systole from the trailing edge of the posterior
ortic wall to the leading edge of the posterior LA.
Baseline CharacteristicsTable 1 Baseline Characteristics
LA Termination
(n  104)
RA
Age, yrs 58 10 6
Males 79%
AF duration 12 (6–20)*† 23
Hypertension 27%
SHD 41%
Emboli 5%
Heart failure 19%
No AAD 2.5 (2–3) 3
LVEDD 53 (48–57) 52
LVESD 36 (30–41) 35
LVEF 56 13 5
LA parasternal 48 8* 4
LA longitudinal 61 7* 6
LA transversal 45 (42–50)* 43
RA longitudinal 54 (49–58)* 56
RA transversal 39 7* 4
Values are mean SD, %, or n (range). Data compared using analysis
test for categorical data. *Statistically significant p values 0.05. †St
Abbreviations
and Acronyms
AF  atrial fibrillation
AT  atrial tachycardia
CL  cycle length
CS  coronary sinus
LA  left atrium
LAA  left atrial
appendage
PsAF  persistent atrial
fibrillation
PV  pulmonary vein
PVI  pulmonary vein
isolation
RA  right atrium
RF  radiofrequency
RAA  right atrial
appendage
SR  sinus rhythm
SVC  superior vena cavaAAD  antiarrhythmic drug; AF  atrial fibrillation; LA  left atrium; LVE
ejection fraction; LVESD  left ventricular end-systolic diameter; RA  right aSurface electrocardiogram and bipolar endocardial elec-
rograms were monitored continuously and stored on a
omputer-based digital amplifier/recorder system (Lab-
ystem Pro, Bard Electrophysiology, C. R. Bard Inc.,
owell, Massachusetts). Intracardiac electrograms were fil-
ered from 30 to 500 Hz.
The following catheters were introduced through the right
emoral vein for the electrophysiological study: 1) a steerable
uadripolar or decapolar catheter (Xtrem, formerly ELA Med-
cal LLC, Plymouth, Minnesota), 5-mm electrode spacing,
as positioned within either the coronary sinus (CS) with the
roximal electrode positioned at 4 to 5 o’clock along the mitral
nnulus or the left atrial appendage (LAA) or the lateral RA;
) a 10-pole circumferential catheter was used for mapping the
ulmonary veins (Lasso, Biosense-Webster, Diamond Bar,
alifornia), and was introduced after transseptal access through
long sheath (SLO, St. Jude Medical, Sylmar, California)
erfused continuously with heparinized D5W; after PVI, this
atheter was placed in either the LAA or RAA; and 3) an
rrigated-tip radiofrequency (RF) ablation catheter with a distal
.5-mm tip (Thermocool, Biosense-Webster). For RA abla-
ion, the ablation catheter was introduced through the long
heath. After transseptal puncture, a single bolus of heparin, 50
U/kg, was administered.
tudy protocol. The procedural end point was termination
f AF to either an intermediate atrial tachycardia (AT) or
irectly to sinus rhythm (SR) by RF application during the
ndex procedure. After restoration of SR, PVI was re-
hecked and conduction across any of the linear lesions
erformed (15,16). Additional RF applications were per-
ormed to achieve PVI and linear block. No attempt at
einduction was made. Duration of RF in the RA was
imited to 25 min, as LA ablation of fractionated activity is
nation
4)
Nontermination
(n  20) p Value
1 58 11 0.72
80% 0.89
8)* 35 (12–72)† 0.001*†
28% 0.92
50% 0.74
12% 0.56
26% 0.76
3 (2–3) 0.75
1) 54 (50–60) 0.33
4) 39 (34–44) 0.45
2 55 14 0.49
*† 57 9*† 0.001*†
*† 67 9† 0.01*†
7)*† 51 (45–57)† 0.009*†
1) 58 (53–66)* 0.02*
45 8* 0.005*
nce (ANOVA) for means, ANOVA on ranks for medians, and chi-square
lly significant difference between marked variables.Termi
(n  2
0 1
83%
(12–4
23%
46%
5%
8%
(1–3)
(48–6
(28–4
9 1
8 7
1 7
(40–4
(52–6
2 7
of varia
atisticaDD  left ventricular end-diastolic diameter; LVEF  left ventricular
trium; SHD  structural heart disease.
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March 9, 2010:1007–16 Role of RA in Long-Lasting Persistent AFormally completed within this time. If AF persisted, SR
as restored by electrical cardioversion.
eft atrial ablation. OSTIAL PVI. Ostial PVI was per-
ormed with the end point of the abolition or dissociation of
lectrical activity in all PVs. After PVI, the Lasso catheter
as withdrawn from the long sheath and advanced via an
ntroducer to the right atrial appendage (RAA) for moni-
oring RA AF CL while the ablation catheter or the
ecapolar catheter was advanced in the LAA for monitoring
F CL.
LECTROGRAM-GUIDED ABLATION. Electrogram-guided
blation was performed at LA sites displaying complex
lectrogram features: continuous electrical activity, complex
apid and fractionated electrograms, a gradient of activation
a temporal gradient of at least 70 ms between the distal and
roximal bipoles on the roving distal ablation electrode) that
ay represent local circuits (8). Areas commonly targeted in
blation of fractionated electrograms included the inferior
A/CS, base of the LAA, the LA roof, and the LA septum,
lthough any areas harboring fractionated electrograms were
argeted. When ablation of the inferior LA did not result in
rganization of the CS, additional ablation within the CS
as performed. The end point of electrogram-guided abla-
ion was the transformation of complex fractionated elec-
rograms into discrete electrograms and slowing of local CL
ompared with LAA AF CL or the elimination of
lectrograms.
INEAR ABLATION. Linear ablation was performed if AF
ersisted after the previous steps, and targeted the LA roof,
hen the mitral isthmus, with the end point of significant
eduction (80%) or abolition of local electrograms.
ight atrial ablation. Ablation was carried out in the RA
f a frequency gradient from RA to LA (RAA AF CL less
han LAA AF CL) was observed after elimination of all LA
Figure 1 Measurement of AF CL
A circular mapping catheter and the ablation catheter are placed in the right atrial
ware with manual correction where necessary, the atrial fibrillation (AF) cycle lengt
determined from 30 s continuous recording, and in this example, the CL of the rigources in AF. Complex fractionated atrial electrograms
ere targeted using the same criteria as in the LA.
IGHT ATRIAL SUBSTRATE ABLATION. Right atrial sub-
trate ablation was performed at the anterior, lateral, and
osterior RA.
BLATION IN THE RAA. Ablation in the RAA was guided by
he Lasso catheter, which was inserted into the body of the
AA, with ablation proximal to the catheter. The end point
f ablation was organization and slowing of RAA electro-
rams and not RAA isolation.
AVOTRICUSPID ISTHMUS ABLATION. Cavotricuspid isth-
us ablation was performed in all patients to achieve
idirectional conduction block (17).
UPERIOR VENA CAVA (SVC) ISOLATION. SVC isolation was
erformed (using the same technique and end point as used
or the PVs) only if it was identified as an AF source on the
asis of descending RA activation using either the decapolar
r RF catheter, with distal to proximal activation within the
VC (18).
F CL. The effect of ablation was monitored, as previously
escribed (19), by evaluation of the AF CL. The AF CL in
he RAA was measured with the RF or decapolar catheter
efore ablation and continuously monitored using the Lasso
atheter after PVI. In the LAA, AF CL was measured
efore ablation, after PVI, after ablation of LA tissue, and
fter linear lesion using the RF catheter. The AF CL was
veraged over 30 s of consecutive cycles using automated
L monitoring software (Labsystem Pro, Bard Electro-
hysiology) (Fig. 1). The electrograms within the body of
he appendages are usually unfractionated and of high
mplitude (0.5 to 2.0 mV), thereby facilitating unambiguous
utomatic annotation. Each automated annotation was
dage (RAA) and left atrial appendage (LAA), respectively. Using automated soft-
is measured synchronously using unambiguous recordings. The mean AF CL is
um is 151 ms and the left atrium is 161 ms.appen
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Role of RA in Long-Lasting Persistent AF March 9, 2010:1007–16erified manually and corrected using online calipers at a
aper speed of 100 mm/s. In addition, the sites of AF
ermination were noted. A significant impact of ablation
as defined by termination of AF or prolongation of the
F CL by 5 ms or more.
Termination of AF was defined as a transition from AF
o SR directly or through 1 or more intermediate AT
ithout antiarrhythmic drugs. The AF was defined by
eat-to-beat variability in cycle length and f-wave morphol-
gy, whereas AT was defined as an organized atrial rhythm
ith a stable cycle length, a consistent endocardial activation
equence in both atria, and a monomorphic P-wave. Orga-
ized AF (type 1 AF) was defined as irregular atrial cycle
ength with beat-to-beat variation of 20 ms, and a
onsistent activation pattern for 75% of the time (20,21). A
requency gradient between the AF CL in the LA and RA
as considered present if a difference of 5 ms was
bserved.
blation parameters. The RF energy was delivered to
trial tissue with a power of 25 to 35 W using irrigation
ates of 5 to 60 ml/min (0.9% saline through a Cool Flow
ump, Biosense-Webster) to achieve the desired power
elivery. Within the CS, power was reduced to 15 to 20 W
istally and 30 W at the CS ostium. Power was limited to
5 W in either appendage. Temperature was limited to
0°C. The duration of RF delivery was measured at each
oint.
ollow-up. All patients were monitored in the hospital for
t least 5 days after their procedure for extensive ambulatory
onitoring. After ablation, all antiarrhythmic drugs were
ot initiated unless otherwise indicated. Patients were
eevaluated at 1, 3, 6, and 12 months, and in the absence of
F or symptoms, followed up with their referring physician.
t each visit, exercise testing and ambulatory 48-h moni-
oring were performed to detect asymptomatic arrhythmias.
n the event of symptomatic or asymptomatic arrhythmia
ecurrence, patients were offered additional ablation at least
months after the index procedure and after a trial of drug
herapy (class IC drug with the addition of beta-blockers, or
n case of concomitant structural heart disease, amiodarone
as administered). Cessation of anticoagulant therapy was
onsidered 6 to 9 months after the last procedure in the
bsence of recurrence or concomitant indications.
tatistical analysis. Data are expressed as mean  SD for
ormally distributed continuous variables, and as the me-
ian (25th, 75th percentiles) for non-normally distributed
ariables. Data are expressed as absolute numbers and
ercentages for categorical variables. Continuous variables
ere compared between groups using Student t test, or the
ann-Whitney rank test, and within each group using a
aired t test or Wilcoxon signed-rank test. Categorical
ariables were compared with the chi-square test or Fisher
xact test. Statistical significance was established at p 
.05.
Multivariate analyses were performed using a multipleinear regression test and included all parameters with aignificance 0.1 from the univariate analysis. Kaplan-
eier analyses for AF-free survival were performed for all 3
roups and were compared using a log-rank analysis.
esults
inus rhythm was restored by ablation without pharmaco-
ogical or direct current cardioversion in 128 patients (86%)
Fig. 2). The total procedure and fluoroscopic times were
52  60 min and 79  19 min (3.75 frames/s), respec-
ively. The total RF ablation duration delivered in both atria
as 85  25 min. PVI was achieved in all patients. During
A ablation, 2 distinctive patterns of AF CL evolution were
bserved in patients in whom procedural termination of AF
as achieved. The AF CL in each group and at every step
s depicted in Table 2.
roup 1: parallel increase in AF CL during LA ablation.
n 104 patients (70%), there was a parallel increase of AF
L in the LA and RA culminating in AF termination. At
aseline, AF CL was 153 ms (range 140 to 170 ms) in LA
nd 155 ms (range 143 to 171 ms) in RA; prolonging after
V isolation to 164 ms (range 152 to 180 ms) and 170 ms
range 152 to 184 ms) (p  0.001 LA vs. RA) and during
A ablation before termination to 181 ms (range 170 to 200
s) and 186 ms (range 175 to 202 ms) (p  0.009 LA vs.
A), respectively (Fig. 3A). In addition to the parallel
attern of evolution, AF CL remained significantly shorter
n LA than RA before AF termination. The AF terminated
irectly to SR in 19 (18%) or via an intermediate AT in
5 (82%).
A total of 171 different ATs were mapped in 85 patients
1.9  1.1 per patient), and were macro–re-entrant in 90
53%) and focal in 81 (47%). The mechanisms of 6 ATs
ould not be defined because of inadvertent termination or
ther factors. Macro–re-entrant tachycardias were termi-
ated by linear ablation at the mitral isthmus (n  45), LA
oof (n  22), or CTI (n  23). Eighty-one centrifugal AT
Figure 2 Patient Flow Chart
AF  atrial fibrillation; DC  direct current; LA  left atrium; RA  right atrium.
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March 9, 2010:1007–16 Role of RA in Long-Lasting Persistent AFere ablated, 47% consistent with focal mechanisms and
3% with localized re-entry.
The RF delivery in the LA lasted 34  14 min for PVI,
9  9 min for electrogram-based ablation, and 20  15
in for the roof and mitral isthmus lines.
roup 2: divergent progression of AF CL during LA
blation. In 44 patients (30%), AF CL remained shorter in
he RA than the LA, and AF did not terminate after LA
blation. In these patients, AF CL at baseline was 140 ms
range 133 to 156 ms) in LA and 145 ms (range 135 to 160
s) in RA; it changed after PVI to 160 ms (range 152 to
70 ms) in LA and 151 ms (range 142 to 162 ms) in RA
p  0.05 LA vs. RA), and during LA ablation before
ermination to 177 ms (range 164 to 194 ms) in LA, and
56 ms (range 146 to 175 ms) in RA (p 0.001 LA vs. RA)
Figs. 3B and 3C).
The RA ablation terminated AF in 24 of these patients
55%, group 2a) directly to SR in 3 and through interme-
iate AT in 21 (87%). The remaining 20 patients under-
ent electrical cardioversion (45%, group 2b).
roup 2a: AF termination after RA ablation. Termina-
ion of AF by ablation in the RA was preceded by an
ncrease in RA AF CL from 145 ms (range 139 to 162 ms)
o 181 ms (171 to 209 ms) (p  0.002). Applications of RF
or 13 7 min at these sites increased right and left AF CL
y 14  9 ms and 6.2  5 ms, respectively. Sites where
blation prolonged RA AF CL were widely distributed but
referentially clustered on the anterior RA, RAA, and
ateral RA. Ablation at the anterior RA and the RAA
ignificantly prolonged AF CL (5 ms) in 14 patients
58%) whereas RF energy delivered to other sites such as
osterior RA (3.4  2.6 min), SVC (2.7  1.6 min), right
eptum (1.5 2.2 min), and CTI (7.1 3.7 min) produced
smaller AF CL prolongation (mean of 4.6  5 ms, 3  5
s, 4 7.4 ms, 4 7.4 ms, and 4.3 7.3 ms, respectively).
Sites where ablation terminated AF were the RAA and
nterior RA in 13, posterior RA in 3, CTI in 3, right
Procedural Characteristics and Clinical OutcomeTable 2 Procedural Characteristics and Clin
LA Termination
(n  104)
Baseline RAA CL, ms 155 (143–171)*
Baseline LAA CL, ms 153 (140–170)*
RAA CL after PVI, ms 170 (152–184)*
LAA CL after PVI, ms 164 (152–180)
RAA CL after LA ablation, ms 186 (175–202)*†
LAA CL after LA ablation, ms 181 (170–200)
Total RF duration, min 81 24*
Procedure duration, min 240 (200–286)
Fluoroscopic duration, min 82 (62–97)
Long-term clinical success, n 97 (93%)*
Values are n (range), mean SD, n (%). Data compared using analysis
test for categorical data. *Statistically significant p values 0.05. †St
CL  cycle length; LAA  left atrial appendage; PVI  pulmonary veptum in 3, lateral RA in 1, and terminal crest in 1 (Fig. 4). Rlectrograms at these sites demonstrated very rapid activity,
ith an average local CL of 136  66 ms.
A total of 36 AT were mapped and ablated in 21 patients
fter RA ablation (1.6  0.9 per patient). Underlying
echanisms were macro–re-entry in 17 (9 perimitral flutter,
rotating around the right PVs and 3 CTI dependent
utters), and centrifugal AT in 13 (10 focal and 3 localized
eentry): 3 from the PVs, 3 from anterior LA, 2 around
ossa ovalis, 2 from RA sites, and 3 from other sites, and
blation restored SR.
In these patients, RF delivery was 33  13 min for PVI,
3  9 min for LA electrogram-based ablation, and 16  7
in for roof and mitral isthmus lines. In the RA, total RF
elivery was 9  5.8 min, with an additional 3.2  2.6 min
or the CTI line.
roup 2b: failure to terminate AF. In 20 patients, AF did
ot terminate despite biatrial ablation, and direct current
ardioversion was needed to restore SR. In this subgroup,
aseline AF CL was 140 ms (range 133 to 158 ms) and 144
s (range 130 to 155 ms) in LA and RA, respectively (p 
S compared with group 2a). The LA ablation of fraction-
ted electrograms and linear lesion at the LA roof and at the
itral isthmus prolonged AF CL in both atria but to a lesser
xtent (LA 165 ms [range 156 to 195 ms], and RA 160 ms
143, 175 ms]; p  0.001).
mpact of ablation. The gradient after LA ablation be-
ween right and left AF CL was significantly smaller in
roup 1 (3 ms [range 2 to 5 ms]) versus group 2 (group 2a,
7 ms [range 10 to 30 ms]; group 2b, 18 ms [range 7 to
1 ms], p  0.001).
Compared with group 2a, ablation of electrograms at the
nterior RA and RAA in group 2b resulted in a smaller
ncrease in global AF CL (14 9 ms vs. 6 5 ms, p 0.1).
blation at the lateral RA increased AF CL by 7  4 ms
ersus 6  5 ms (p  NS), whereas targeting other sites
uch as posterior RA, right septum, and CTI resulted in
maller increases in global AF CL (3.1  1.6 ms, 4.5  0.7
s, and 3  2.6 ms, respectively; p  NS). At all RA sites,
utcome
Termination
(n  24)
RA Nontermination
(n  20) p Value
(139–162) 144 (130–155)* 0.04*
(143–153) 140 (133–158)* 0.03*
(142–161)* 153 (129–173) 0.02*
(153–170) 155 (137–165) 0.49
(147–173)* 160 (143–175)† 0.001*†
(165–185) 165 (156–195) 0.09
89 23 104 19* 0.001*
(231–330) 270 (215–290) 0.08
(76–101) 94 (79–102) 0.12
(88%)† 11 (55%)*† 0.001*†
nce (ANOVA) for means, ANOVA on ranks for medians, and chi-square
lly significant difference between marked variables.
ation; RAA  right atrial appendage; RF  radiofrequency.ical O
RA
145
142
151
160
152
177
270
85
21
of variaF delivery was significantly longer for group 2b than for
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Role of RA in Long-Lasting Persistent AF March 9, 2010:1007–16roup 2a in whom AF terminated (total RA ablation, 22 
min vs. 9  6 min, p  0.001). The LA electrogram-
ased ablation was also longer for group 2b than for group
a (31  15 min vs. 23  10 min, p  0.05).
actors predictive of RA ablation. The pre-procedural
actors that were predictive of the need for RA ablation in
nivariate analysis were a longer duration of continuous AF
p 0.001) and a larger LA parasternal dimension (p 0.03),
A size (p  0.01) (Table 3). In a multivariate model
ncluding duration of AF, LA, and RA size and baseline AF
L both duration of continuous AF (p  0.01) and RA size
p  0.05) were predictive of the need for RA ablation. The
ensitivity and specificity of a duration of continuous AF 20
onths were 79% and 62%, respectively, with an area under
he curve of 0.75 (p 0.0001). The sensitivity and specificity
f an RA diameter of 38 mm were 49% and 76%,
espectively, with an area under the curve of 0.64 (p 0.01).
The procedural factors that were predictive of the need
or RA ablation in univariate analysis were baseline LA AF
L (p 0.01), baseline RA AF CL (p 0.02), RA AF CL
fter PVI (p  0.01), RA AF CL after LA ablation (p 
.001), and LA AF CL after LA ablation (p 0.05) (Table
). In a multivariate model including baseline LA AF CL,
aseline RA AF CL, RA AF CL after PVI, RA AF CL
fter LA ablation, and LA AF CL after LA ablation, only
A AF CL after LA ablation (p  0.001) and LA AF CL
fter LA ablation (p  0.001) were predictive of the need
or RA ablation. The sensitivity and specificity of an LA AF
L of 165 ms after LA ablation were 42% and 88%,
espectively, with an area under the curve of 0.64 (p 0.01).
he sensitivity and specificity of an RA AF CL of160 ms
fter LA ablation were 62% and 97%, respectively, with an
rea under the curve of 0.84 (p  0.0001).
actors predictive of AF termination after RA ablation. In
multivariate model including factors identified by univariate
nalysis as potential predictors (duration of continuous AF,
A, and RA size), only LA size 51 mm (odds ratio: 0.87,
5% confidence interval: 0.79 to 0.96, p  0.003) was
ndependently predictive of AF termination after RA ablation.
ollow-up and subsequent clinical outcome. With a
ollow-up of 22  9 months and a mean of 1.5 procedures
er patient, 129 patients (87%) were in SR. There was a
isparate clinical outcome among the 3 groups (Fig. 5). The
uccess rate after a single procedure was 46% for patients in
hom AF terminated, and 10% for patients in whom AF
id not terminate (p  0.005). After the last procedure,
table SR was maintained in 93% of patients in group 1
including 16% receiving an antiarrhythmic drug), 88% in
roup 2a (including 38% with an antiarrhythmic drug), and
nly 55% of patients in group 2b (including 36% with an
ntiarrhythmic drug). The detailed follow-up is depicted as
flow chart in Figure 6.
dverse affects. Two patients had pericardial tamponade
during LA ablation) that required pericardiocentesis. In
nother patient, a transient ischemic attack occurred on theFigure 3 Evolution of AF CL During Ablation
(A) In group 1, AF CL measured from both the RAA (red line) and LAA (blue
line) prolongs in parallel, with termination of AF occurring in the left atrium. (B)
In group 2a, where termination occurs during right atrial ablation, the AF CL
prolongs in the left atrium (blue line) but not in the right atrium (red line) with
LA ablation. (C) In group 2b, the AF CL measured in the right atrium (red line)
fails to prolong after pulmonary vein (PV) isolation. The blue line indicates the
left atrium. Data were compared using analysis of variance on ranks to com-
pare AF CL at baseline and after each step of the ablation inside each atrium,
with the p value representing the difference in AF CL occurring during ablation
inside each atrium. Abbreviations as in Figures 1 and 2.ay after the procedure.
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his study presents new information on the relative role of
he left and right atria in the maintenance of long-lasting
sAF. We found that 1) biatrial monitoring of AF CL
evealed 2 patterns of AF CL evolution: parallel RA and LA
L prolongation in the majority of patients and divergent
volution of AF CL in 20% of patients, with a right to left
requency gradient; 2) for patients in whom LA and RA AF
L prolonged in parallel, LA ablation alone resulted in AF
ermination; 3) for patients with an RA to LA frequency
Figure 4 Sites of AF Termination Within Right Atrium
(A) AF  atrial fibrillation; Ant  anterior right atrium; CTI  cavotricuspid isthmus
RAA  right atrial appendage; Sept  right atrial septum; SVC  superior vena ca
at the base of the RAA. Lower panel: Lasso recordings within the right appendage
re-Procedural Characteristicssed in Logistic Regress on ModelTable 3 Pre-Procedu al CharacteristicsUsed in Logistic Regression Model
LA Termination
(n  104)
RA ablation
(n  44) p Value
AF duration 12 (6–20) 24 (12–66) 0.001
LVEDD 53 (48–57) 54 (48–60) 0.29
LVESD 36 (30–41) 38 (31–44) 0.32
LVEF 56 13 58 13 0.53
LA parasternal 48 8 52 9 0.03
LA longitudinal 61 7 63 8 0.13
LA transversal 45 (42–50) 46 (43–53) 0.11
RA longitudinal 54 (49–58) 56 (52–65) 0.01
RA transversal 40 (34–44) 42 (39–50) 0.01
alues are n (range) or mean  SD. Data compared using Student t test for means and
ann-Whitney rank test for medians. Univariate data p 0.25 used in multiple logistic regression
odel.
Abbreviations as in Table 1.
iradient, ablation targeted to the RA terminated AF in 50%
f patients; 4) in these patients, the anterior RA and RAA
ppeared to be critical structures to maintain AF, and
blation at these sites resulted in termination of AF in 55%
f all patients where termination occurred in the RA; and 5)
re-procedural and procedural independent predictors of
he need for RA ablation were duration of continuous AF,
A size, and right and left AF CL after LA ablation.
revious studies. Prior studies have indicated that the RA
ay drive AF in some cases, and dominant frequency
apping in persistent AF uncovered in RA dominant
requency max sites in 16% of patients (22). There are clear
eports of AF termination during exclusive or dominant
 inferior vena cava; Lat  lateral right atrium; Post  posterior right atrium;
 terminal crest; TV  tricuspid valve. (B) Upper panel: Site of AF termination
ing conversion of the AF to atrial tachycardia.
rocedural Characteristicssed in Logistic Regression ModelTable 4 Procedu al CharacteristicsUsed in Logistic Regression Model
LA Termination
(n  104)
RA Ablation
(n  44) p Value
Baseline RAA CL, ms 155 (143–171) 145 (135–160) 0.02
Baseline LAA CL, ms 153 (140–170) 140 (133–156) 0.01
RAA CL after PVI, ms 170 (152–184) 151 (142–162) 0.005
LAA CL after PVI, ms 164 (152–180) 160 (152–170) 0.49
RAA CL after LA ablation, ms 186 (175–202) 156 (146–175) 0.001
LAA CL after LA ablation, ms 181 (170–200) 177 (164–194) 0.04
alues are n (range). Data compared using Mann-Whitney rank test. Univariate data p 0.25 used; IVC
va; TC
shown multiple logistic regression model.
Abbreviations as in Table 2.
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23,24).
In the present study, in the majority of patients with
ong-lasting PsAF, LA ablation prolonged AF CL in both
tria, culminating in AF termination, clearly indicating that
he LA was driving the RA and thus the fibrillatory process.
t follows that RA ablation is not appropriate for all
atients, which may explain why some studies do not show
benefit of indiscriminate RA ablation (13,25).
However, our results are similar to those of other studies
n which both the LA and RA have been targeted. In a
ecent study using biatrial ablation, AF termination oc-
urred in the RA in 26% of patients (14). Interestingly, as in
ur study, there was a frequency gradient from the RA to
he LA in these patients. In an earlier study based on
lectrogram-targeted ablation, 60% of PsAF could be ter-
inated, of which 15% occurred in the RA (1). A subse-
uent study compared LA ablation to biatrial ablation in 80
atients with PsAF; procedural termination of AF was more
requent with biatrial than with LA ablation (85% vs. 24%)
24). However, AF-free survival without antiarrhythmic
edications in that study was limited to 35% to 47%. A
eries of small biatrial mapping studies of chronic AF have
ccasionally identified rapid repetitive activations in the
ateral RA (26).
ole of the RA. In 30% of our total population, AF CL in
he RA did not prolong in parallel with AF CL in the LA,
esulting in a right to left frequency gradient, suggesting
hat the substrate resides in the RA. This hypothesis was
onfirmed by AF termination with RA ablation in more
han one-half of these patients. Interestingly, the RA AF
L was shorter in these patients after PVI, and it may be
Figure 5 Arrhythmia-Free Survival by Site of Arrhythmia Termin
Kaplan-Meier analysis of the recurrence of any atrial arrhythmia (atrial fibrillation o
tachycardia): group 1, left atrial termination; group 2a, right atrial termination; andhat biatrial monitoring of AF CL with ablation targeted to she chamber with the shortest AF CL after PVI will avoid
nnecessary ablation.
Although sites associated with AF termination in the RA
ere widely distributed, the 2 predominant areas were the
nterior RA and RA appendage. Although RA focal or
eentrant tachycardias have been mainly described in supe-
ior vena cava, crista terminalis, or atrial septum, the
verlapping heterogeneity of trabeculated fibers between
AA and RA body (27) may constitute a critical milieu for
erpetuation of AF in some patients, as with the LAA.
Among patients requiring RA ablation to terminate AF,
8% converted to SR through an intermediate AT. It is
otable that these ATs were mainly left atrial (73%). These
ata support the multiple concurrent driver hypothesis of
F (28). Somewhat speculatively, it is possible that the
limination of LA sources for AF by ablation enabled the
mergence of slower RA sources. Successful ablation of
hese sources, in turn, terminated AF. Further studies are
eeded to determine if the LA AT to which AF subse-
uently terminated were due to preceding LA ablation, or
eflected organization from still slower residual LA sources
or AF.
Multivariate analysis demonstrated that duration of long-
asting PsAF, RA size, and right and left AF CL after LA
blation were independent predictors of the need of RA
blation. These variables can help identify patients who will
equire RA ablation. This suggests that as the AF process
volves, initial remodeling occurs in the LA, but then later
he RA becomes recruited into the pathological process.
The present study does not provide information on
hether some patients may have benefited from RA abla-
ion alone. An earlier study showed that AF may originate
l
2b, nontermination. Log rank p  0.0001.ation
r atria
groupolely from the RA could effectively be ablated by targeting
t
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onstituted 3% of the screened population.
tudy limitations. The main limitation of this study is that
blation was targeted to the RA only after ablation in the
A was completed. However, a right to left frequency
radient was often apparent after PVI, suggesting that the
A could have been targeted earlier. This study may,
herefore, underestimate the contribution of the RA in
atients with long-lasting PsAF. Secondly, electrogram
nalysis based on visual inspection is somewhat subjective
30); however, this is true for prior studies, and attempts to
uantify successful ablation sites using frequency analysis in
ong-lasting PsAF have had conflicting results (31,32).
lthough considerable atrial damage may result from abla-
ion to terminate long-lasting PsAF (8), echocardiography
howed that atrial systolic function was retained in all
atients in SR (33). Thirdly, we measured the impact of
blation through changes in AF CL, yet it is possible that
he fibrillatory process was also modulated by ablation that
id not alter AF CL. Finally, it is also possible that critical
rivers may be present in the RA and conduct to the LA
Figure 6 Outcomes Flow Chart
Outcome of patients in group 1 (left atrial termination), group 2a (right atrial termi
tion; AT  atrial tachycardia; DCC  direct current conversion; FU  follow-up; LA
RA  right atrium; SR  sinus rhythm.ithout a frequency gradient.
Bonclusions
blation of RA substrate is required to terminate long-
asting PsAF and achieve durable long-term results in 20%
f patients. These patients tend to have a longer duration of
F, larger RA size, and shorter right and left AF CL after
A ablation, resulting in a right to left frequency gradient.
lthough these patients have a lower overall success rate
han do patients in whom LA ablation alone is successful,
dditional ablation within the RA terminated AF in more
han one-half, with a long-term outcome similar to that of
atients who had procedural termination in the LA. Ter-
ination of AF, whether occurring in the RA or LA, is
ssociated with an excellent long-term outcome. Further
tudies are needed to elucidate the complex interplay be-
ween left and right atrial sources for AF.
eprint requests and correspondence: Dr. Mélèze Hocini,
ôpital Cardiologique du Haut-Lévêque, Avenue de Magellan,
), and group 2b (nontermination). AAD  antiarrhythmic drug; AF  atrial fibrilla-
atrium; PAF  paroxysmal atrial fibrillation; PsAF  persistent atrial fibrillation;nation
 leftordeaux 33604, France. E-mail: meleze.hocini@chu-bordeaux.fr.
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